Increasing Vaccine Share
First written in FY2019. 3 of 7 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Revenue increased due in part to the Company’s focus on sales of products eligible for the new drug creation incentive, mainly anticancer drugs, influenza vaccines and seasonal products such as antiallergic drugs.」
The Company states that its focus on anticancer drugs, products eligible for the new drug creation incentive and influenza vaccines contributed to higher revenue in the Pharmaceutical Wholesale Business. - FY2025AdvancedAnnual report
「In addition to growth in sales of test kits and treatments driven by the influenza outbreak, sales growth in products eligible for the new drug creation incentive, mainly anticancer drugs, as well as cervical cancer vaccines and a new COVID-19 vaccine introduced in October, exceeded the decline in other sales, resulting in higher revenue.」
Regarding vaccines, the Company states that growth in sales of cervical cancer vaccines and the new COVID-19 vaccine contributed to full-year revenue growth. - FY2025-H1AdvancedAnnual report
「The Company conducted activities to raise awareness of the importance of receiving cervical cancer vaccinations, which made a significant contribution to higher sales.」
The Company promoted cervical cancer vaccination through activities with local governments and medical associations, contributing to higher sales. - FY2023-Q2RestatedAnnual report
「The Company will focus mainly on sales of various vaccines, centred on products eligible for the new drug creation incentive and influenza vaccines,」
As a measure related to increasing vaccine market share, the Company continues to focus on sales of various vaccines, particularly influenza vaccines. - FY2023-Q1RestatedAnnual report
「While the prior year-end inventory mentioned above was sold down and the negative accounting treatment was eliminated, the Company plans to focus this summer on sales of various vaccines for which demand is expected to increase, among other measures,」
In connection with the theme of increasing vaccine market share, the Company has specified its focus on sales of various vaccines for which demand is expected to increase this summer. - FY2020RestatedAnnual report
「Increasing Vaccine Share」
The Company continues to pursue increasing vaccine market share as a practical challenge under its pharmaceutical wholesale business strategy. - FY2019First statedAnnual report
「Increasing Vaccine Share」
The Company has identified increasing vaccine market share as a practical challenge under its pharmaceutical wholesale business strategy.